Respiratory syncytial virus replication inhibitors

US6747028B1 · kind B1 · utility

Assignee

• Hanssen Pharmaceutica, N.V. · BE

Inventors

• Frans Eduard Janssens · Bonheiden, BE
• Kathleen Petrus Marie-José Meersman · Wechelderzande, BE
• François Maria Sommen · Wortel, BE
• Koenraad Jozef Lodewijk Marcel Andries · Beerse, BE

Key dates

• Filing date: Dec 27, 2001
• Grant date: Jun 8, 2004
• Expiry date: Feb 15, 2022

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/55
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention concerns compounds of formula (I) prodrugs, addition salts, or stereochemically isomeric forms thereof for use as, inter alia, respiratory syncytial virus replication inhibitors; their preparation, compositions containing them and methods of their use in treating respiratory syncytial viral infections.